Literature DB >> 18533238

Contribution of demographic, psychological and disease-related factors to quality of life in women with high-grade vulval intraepithelial neoplasia.

T S Shylasree1, V Karanjgaokar, A Tristram, A R Wilkes, A B MacLean, A N Fiander.   

Abstract

OBJECTIVES: To quantify the effect of demographic, psychological and disease-related factors on Quality of life (QoL) outcomes in women with high-grade vulval intraepithelial neoplasia (VIN2-3). To obtain qualitative data on the effect of disease and treatment in these women and their partners. To assess the participants' perception of their risk of developing of vulval cancer and its relation to QoL outcomes.
METHODS: A questionnaire was constructed using existing instruments to measure the effect of demographic, psychological and disease-related factors on QoL outcomes. Free text space was provided for qualitative data. The questionnaire was mailed to women attending two specialist VIN clinics.
RESULTS: One hundred and fifty women were invited for the study. Eighty-two responded (54.6%) of which forty-four (53.6%) were sexually active. Demographic factors (age and or living situation) had a significant effect on emotional health and body image. Psychological factors (anxiety and depression) had a significant effect on all aspects of QoL. Disease-related factors did not have a measurable effect on QoL outcomes, although the qualitative data revealed that various aspects of VIN had affected the lives of these women and their partners. There was a significant positive association between a perceived risk of developing vulval cancer with worsening general and emotional health.
CONCLUSION: Psychological co-morbidity and various demographic factors should be considered while managing women with VIN. Accurate information regarding the development of vulval cancer should be given. The findings of this preliminary study will assist the construction of VIN-specific QoL instruments in the future.

Entities:  

Mesh:

Year:  2008        PMID: 18533238     DOI: 10.1016/j.ygyno.2008.04.023

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.

Authors:  S Daayana; E Elkord; U Winters; M Pawlita; R Roden; P L Stern; H C Kitchener
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

Review 2.  Does treatment for cervical and vulvar dysplasia impact women's sexual health?

Authors:  Blanca R Cendejas; Karen K Smith-McCune; Michelle J Khan
Journal:  Am J Obstet Gynecol       Date:  2014-05-29       Impact factor: 8.661

Review 3.  Therapy of human papillomavirus-related disease.

Authors:  Peter L Stern; Sjoerd H van der Burg; Ian N Hampson; Thomas R Broker; Alison Fiander; Charles J Lacey; Henry C Kitchener; Mark H Einstein
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

Review 4.  Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.

Authors:  Theresa A Lawrie; Andy Nordin; Manas Chakrabarti; Andrew Bryant; Sonali Kaushik; Litha Pepas
Journal:  Cochrane Database Syst Rev       Date:  2016-01-05

5.  Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study in the UK.

Authors:  Géraldine Dominiak-Felden; Catherine Cohet; Samantha Atrux-Tallau; Hélène Gilet; Amanda Tristram; Alison Fiander
Journal:  BMC Public Health       Date:  2013-11-12       Impact factor: 3.295

6.  Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN).

Authors:  C N Hurt; Sef Jones; T-A Madden; A Fiander; A J Nordin; R Naik; N Powell; M Carucci; A Tristram
Journal:  BJOG       Date:  2018-02-09       Impact factor: 6.531

Review 7.  Medical interventions for high-grade vulval intraepithelial neoplasia.

Authors:  Litha Pepas; Sonali Kaushik; Andy Nordin; Andrew Bryant; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2015-08-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.